THERATOME BIO, INC.

Profile

Company Names

THERATOME BIO, INC.
NEUROFX, INC.

Addresses

9128 LAKES AT 610 DRIVE, HOUSTON, TX 77054

11650 LANTERN ROAD, SUITE 253, FISHERS, IN 46038

Phone Numbers

8324525117
317-502-3418

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$1,918,500.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-09-14 
$28,500.00 
$950,000.00 
$921,500.00 
Equity 
1
2016-02-03 
$1,890,000.00 
$3,500,000.00 
$1,610,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT 
A. 
JONES 
DIRECTOR
CHACHA SEARCH INC   |  PRECISE PATH ROBOTICS INC   |  NEUROFX, INC.
WADE 
 
LANGE 
EXECUTIVE OFFICER
IMMUNEWORKS, INC.   |  NEUROFX, INC.   |  AMPLIFIED SCIENCES, INC.
KEITH 
L. 
MARCH 
DIRECTOR
NEUROFX, INC.
KEITH 
 
MARCH MD PHD 
EXECUTIVE OFFICER, DIRECTOR
THERATOME BIO, INC.
BRAD 
 
MILLER 
DIRECTOR
IKASYSTEMS CORP   |  EE MUSEUM MF, LP   |  NEUROFX, INC.
BRAD 
T 
MILLER 
DIRECTOR
THERATOME BIO, INC.
JAMES 
DONALD 
PAYNE 
EXECUTIVE OFFICER
GREENJAY THERAPEUTICS, INC.   |  THERATOME BIO, INC.
MICHAEL 
T 
REDMAN 
EXECUTIVE OFFICER, DIRECTOR
ONCOLIX, INC.   |  ADVANCED ENVIRONMENTAL PETROLEUM PRODUCERS INC.   |  THERATOME BIO, INC.
JENNIFER 
 
RHODES 
EXECUTIVE OFFICER
NEUROFX, INC.   |  E5 INC.
MICHAEL 
DONALD 
TROTTA 
DIRECTOR
THERATOME BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-09-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-09-14 
2016-04-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#